BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2891846)

  • 1. Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies.
    Stevens CW; Monasky MS; Yaksh TL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):63-70. PubMed ID: 2891846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):327-35. PubMed ID: 8093729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):1-8. PubMed ID: 2526212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal infusion of N-methyl-D-aspartate antagonist MK801 induces hypersensitivity to the spinal alpha-2 agonist ST91 in the rat.
    Dunbar SA; Yaksh TL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1219-25. PubMed ID: 9190856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1991 Aug; 258(2):438-46. PubMed ID: 1678011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.
    Monasky MS; Zinsmeister AR; Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):383-92. PubMed ID: 1974633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to intrathecal oxymetazoline-induced analgesia, with paradigm-dependent cross-tolerance to intrathecal morphine.
    Sherman SE; Loomis CW; Milne B; Cervenko FW
    J Pharmacol Exp Ther; 1988 Apr; 245(1):319-26. PubMed ID: 3361450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1989 Oct; 251(1):216-23. PubMed ID: 2795458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine.
    Fairbanks CA; Wilcox GL
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1107-16. PubMed ID: 10027848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents.
    Ossipov MH; Suarez LJ; Spaulding TC
    Anesth Analg; 1989 Mar; 68(3):194-200. PubMed ID: 2537587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
    Ossipov MH; Harris S; Lloyd P; Messineo E
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1107-16. PubMed ID: 2262895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat.
    Sosnowski M; Yaksh TL
    Anesthesiology; 1990 Dec; 73(6):1141-7. PubMed ID: 1978988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of morphine and D-ala2-D-leu5-enkephalin (DADLE) cross-tolerance after continuous intrathecal infusion in the rat.
    Stevens CW; Yaksh TL
    Anesthesiology; 1992 Apr; 76(4):596-603. PubMed ID: 1550284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1992 May; 261(2):764-72. PubMed ID: 1349648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of tolerance to chronic intrathecal morphine infusion in the rat.
    Advokat C; Burton P; Tyler CB
    Physiol Behav; 1987; 39(2):161-8. PubMed ID: 3575449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intrathecal morphine, baclofen, clonidine and R-PIA on the acute allodynia-like behaviours after spinal cord ischaemia in rats.
    von Heijne M; Hao JX; Sollevi A; Xu XJ
    Eur J Pain; 2001; 5(1):1-10. PubMed ID: 11394917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.